Overview

A Model About the Response of Belimumab in SLE

Status:
Not yet recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
A prospective, single-center cohort study aims to determine a predictive model of the response of belimumab at Week 48.
Phase:
Phase 4
Details
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Treatments:
Belimumab